[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.92.62. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Editor's Correspondence
February 23, 2004

Thrombosis Prophylaxis in Cancer Patients With a Central Venous Catheter—Reply

Arch Intern Med. 2004;164(4):459-460. doi:10.1001/archinte.164.4.459-b

In reply

With their study, Laporte and colleagues address an important question with regard to the prevention of catheter-related thrombosis in patients with cancer.1 Until recently, only 2 prospective randomized controlled trials were available on this subject, and although both found a reduction in catheter-related thrombosis with the use of anticoagulants, no definite overall conclusions could be drawn since they studied different types of thromboprophylaxis (low-dose warfarin and low-molecular-weight heparin).2,3 Therefore, there was a need for a study that compared these 2 types of anticoagulants head-to-head. And this is exactly what Laporte and colleagues did.

First Page Preview View Large
First page PDF preview
First page PDF preview
×